Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Alzheimer’s

Recent news which mentions Alzheimer’s

EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says
Tags Market News Alzheimer’s Cannabis
From Benzinga
EXCLUSIVE: Alzamend Seeks FDA Approval For Study For Upgraded Version Of Most Commonly Used Treatment For Bipolar Disorder
Tickers ALZN
Tags Market/Moving Exclusives Exclusives General
From Benzinga
Eli Lilly's Alzheimer's Drug Candidate Slows Progression By 60% In Mildly Impaired Patients
Tickers LLY
Tags Market News Alzheimer’s LLY
From Benzinga
Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
Tickers BIIB ESALF ESALY
Tags ESALF General Government
From Benzinga
Stress-Related Mood Disorders And Alzheimer's: Can This Patented Ketamine Drug Help?
Tickers SILO
Tags Markets Stress/Induced Disorders News
From Benzinga
Will US Medicare Fully Cover Alzheimer's Drugs? Eli Lilly Thinks Yes!
Tickers BIIB ESALF ESALY LLY
Tags Large Cap Biotech BIIB
From Benzinga
National Institute on Aging Aims Building $300M Alzheimer's Research Database
Tickers BIIB ESALF ESALY
Tags Health Care BIIB Biotech
From Benzinga
EXCLUSIVE: Alzamend Neuro Starts Phase 1/2A Trial For Its Alzheimer's Immunotherapy Vaccine
Tickers ALZN
Tags Market News Alzheimer’s Exclusives
From Benzinga
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
Tickers BIIB ESALF ESALY LLY
Tags ESALF Briefs News
From Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Tickers BGNE BIIB CDTX CHRS
Tags Biotech Small Cap FDA
From Benzinga
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
Tickers MOR RHHBF RHHBY RHHVF
Tags Briefs why it's moving News
From Benzinga
Why Shares Of Eli Lilly And Biogen Are Rallying Today
Tickers BIIB ESALY LLY RHHBY
Tags Long Ideas Alzheimer’s Market News
From Benzinga
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
Tickers ABOS ACIU ALZN ANVS
Tags BMY Health Care SAVA
From Benzinga
Flu Shots Can Cut Down Risk Of Alzheimer's, Exploratory Study Finds
Tickers IBB
Tags Benzinga Media IBB
From Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
Tickers BIIB
Tags Alzheimer's disease Biotech BIIB
From Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
Tickers LGVN
Tags Health Care Phase 1 Trial LGVN
From Benzinga
How CBD Helps Seniors With Alzheimer's And Dementia, Start With The Basics!
Tickers CBD
Tags Markets General Benzinga
From Benzinga
Acadia Resubmits Pimavanserin US Application For Expanded Use In Alzheimer's Psychosis
Tickers ACAD
Tags General Health Care ACAD
From Benzinga
Citi Upgrades This Big Pharma Stock On Positive Alzheimer's Expectations
Tickers LLY
Tags Benzinga Trading Ideas LLY
From Benzinga
Cassava Sciences Receives FDA's Special Protocol Assessment For Alzheimer's Trials
Tickers SAVA
Tags Health Care Biotech SAVA
From Benzinga
White House Dismisses Janet Woodcock As Permanent FDA Commissioner Candidate: Bloomberg
Tickers BIIB ESALF ESALY
Tags BIIB Health Care Biotech
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.